Sanofi has appointed Belén Garijo as Chief Executive Officer. In this role, she will oversee the company’s global strategy as it works to strengthen its pipeline, advance key therapeutic programs, and prepare for long-term growth. Garijo will continue leading the organization through a period of transformation and innovation across its global operations.
Garijo is a highly experienced healthcare executive with decades of leadership experience in the pharmaceutical and life sciences sectors. Prior to becoming Chief Executive Officer, she held several senior leadership positions at Sanofi, including responsibility for the company’s pharmaceutical business and global operations. Earlier in her career, she held executive roles at Merck KGaA, where she led international healthcare and specialty medicine businesses.
Why this matters: The pharmaceutical industry is navigating growing pressure to accelerate innovation while managing patent cycles, regulatory complexity, and rising healthcare demands. Garijo’s continued leadership provides strategic continuity for Sanofi as it advances its pipeline and competes for leadership in key therapeutic areas, including immunology, rare diseases, and vaccines.
Join the conversation on LinkedInConnect with Belén Garijo on LinkedIn
